Table 3. Pharmacological agents used in studies.
| Classification | Pharmacological agent | Cases (n=33) |
|---|---|---|
| Antiviral | Acyclovir | 9* (27.27) |
| Atazanavir | 1 (3.03) | |
| Arbidol | 1 (3.03) | |
| Oseltamivir | 1* (3.03) | |
| Darunavir/cobicistat | 1 (3.03) | |
| Lopinavir | 2 (6.06) | |
| Ritonavir | 2 (6.06) | |
| Favipiravir | 8 (24.24) | |
| Antibiotic | Ceftriaxone | 6 (4*; 18.18) |
| Vancomycin | 3 (1*; 9.09) | |
| Levofloxacin | 1 (3.03) | |
| Linezolid | 1 (3.03) | |
| Piperacillin-tazobactam | 1 (3.03) | |
| Amoxicillin | 2 (1*; 6.06) | |
| Ampicillin | 3* (9.09) | |
| Meropenem | 1 (3.03) | |
| Azithromycin | 9 (27.27) | |
| Antiepileptic | Levetiracetam | 6 (18.18) |
| Clonazepam | 2 (12.12) | |
| Valproate | 3 (9.09) | |
| Midazolam | 2 (6.06) | |
| Other | Hydroxychloroquine | 16 (48.48) |
| Mannitol | 1 (3.03) | |
| Norepinephrine | 1 (3.03) | |
| Methylprednisolone | 5 (15.15) | |
| Dexamethasone | 2 (6.06) | |
| Nebivolol | 1 (3.03) | |
| Amlodipine | 1 (3.03) | |
| Quetiapine | 2 (6.06) | |
| Aripiprazole | 1 (3.03) | |
| Haloperidol | 2 (6.06) | |
| Promazine | 1 (3.03) | |
| Paracetamol | 1 (3.03) | |
| Tocilizumab | 2 (6.06) | |
| Heparin, protamine sulfate | 1* (3.03) | |
| Vitamins B and C | 1 (3.03) | |
| Plasmapheresis | 6 (18.18) | |
| IVIg | 4 (12.12) |
Data are presented as n (%).
*Administration was stopped before full course completed.